Suspension of trading

Income Statement Eiger BioPharmaceuticals

Stocks

EIGR

US28249U2042

Biotechnology & Medical Research

Market Closed - OTC Markets 19:27:07 27/09/2024 +04			5-day change	1st Jan Change
8.500 ^USD	-.--%		-.--%	-

01/10/24	Eiger BioPharmaceuticals Files for Chapter 11 Bankruptcy as Liquidation Plan Takes Effect	CI
30/09/24	Eiger BioPharmaceuticals, Inc. Went Out of Business	CI

f362df0011f797109ae40d8.9t-NfIDTe_Bca75yx-u3rBJlGVJsXsi4ETb8-MKi6nQ.uLTORMGqLcRoE9kioqfu4EUdThoJbqrge1TPlZDsrz6prutO0LVKwRY8zQ

Published financial data: EIGER BIOPHARMACEUTICALS

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
Revenues	-	-	12.14M	12.73M	15.52M
Other Revenues, Total	-	-	-	750K	250K
Total Revenues	-	-	12.14M	13.48M	15.77M
Cost of Goods Sold, Total	-	-	745K	1.84M	24K
Gross Profit	-	-	11.4M	11.65M	15.75M
Selling General & Admin Expenses, Total	17.11M	20.56M	23.9M	29.1M	25.2M
R&D Expenses	51.79M	41.59M	64.44M	75.28M	62.33M
Other Operating Expenses, Total	68.9M	62.15M	88.34M	104M	87.54M
Operating Income	-68.9M	-62.15M	-76.94M	-92.74M	-71.79M
Interest Expense, Total	-3.41M	-3.59M	-3.56M	-4.13M	-5.47M
Interest And Investment Income	2.07M	704K	158K	1.08M	2.21M
Net Interest Expenses	-1.33M	-2.89M	-3.4M	-3.05M	-3.26M
Other Non Operating Income (Expenses)	-15K	-12K	46.49M	137K	87K
EBT, Excl. Unusual Items	-70.25M	-65.05M	-33.85M	-95.65M	-74.96M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Other Unusual Items	-	-	-	-1.1M	-
EBT, Incl. Unusual Items	-70.25M	-65.05M	-33.85M	-96.75M	-74.96M
Income Tax Expense	-	-	64K	23K	6K
Earnings From Continuing Operations	-70.25M	-65.05M	-33.92M	-96.78M	-74.96M
Net Income to Company	-70.25M	-65.05M	-33.92M	-96.78M	-74.96M
Net Income - (IS)	-70.25M	-65.05M	-33.92M	-96.78M	-74.96M
Net Income to Common Incl Extra Items	-70.25M	-65.05M	-33.92M	-96.78M	-74.96M
Net Income to Common Excl. Extra Items	-70.25M	-65.05M	-33.92M	-96.78M	-74.96M
Per Share Items
Net EPS - Basic	-92.5	-69.34	-29.98	-69.74	-50.78
Basic EPS - Continuing Operations	-92.5	-69.34	-29.98	-69.74	-50.78
Basic Weighted Average Shares Outstanding	760K	938K	1.13M	1.39M	1.48M
Net EPS - Diluted	-92.5	-69.34	-29.98	-69.74	-50.78
Diluted EPS - Continuing Operations	-92.5	-69.34	-29.98	-69.74	-50.78
Diluted Weighted Average Shares Outstanding	760K	938K	1.13M	1.39M	1.48M
Normalized Basic EPS	-57.81	-43.34	-18.7	-43.08	-31.73
Normalized Diluted EPS	-57.81	-43.34	-18.7	-43.08	-31.73
Supplemental Items
EBITDA	-68.84M	-61.98M	-76.66M	-92.45M	-71.51M
EBITA	-68.9M	-62.15M	-76.94M	-92.74M	-71.79M
EBIT	-68.9M	-62.15M	-76.94M	-92.74M	-71.79M
EBITDAR	-68.14M	-61.28M	-75.96M	-91.75M	-
Total Revenues (As Reported)	-	-	-	13.48M	15.77M
Effective Tax Rate - (Ratio)	-	-	-0.19	-0.02	-0.01
Current Foreign Taxes	-	-	-	-	6K
Total Current Taxes	-	-	-	-	6K
Normalized Net Income	-43.91M	-40.66M	-21.16M	-59.78M	-46.85M
Interest on Long-Term Debt	3.41M	3.59M	3.56M	4.13M	5.47M
Supplemental Operating Expense Items
General and Administrative Expenses	17.11M	20.56M	-	-	-
Research And Development Expense From Footnotes	51.79M	41.59M	64.44M	75.28M	62.33M
Net Rental Expense, Total	700K	700K	700K	700K	-
Imputed Operating Lease Interest Expense	659K	622K	613K	636K	-
Imputed Operating Lease Depreciation	40.75K	78.42K	87.26K	63.77K	-
Stock-Based Comp., R&D Exp. (Total)	1.78M	1.71M	2.47M	3.18M	2.39M
Stock-Based Comp., G&A Exp. (Total)	4.13M	4.48M	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	5.65M	5.16M	2.62M
Total Stock-Based Compensation	5.9M	6.19M	8.12M	8.34M	5.01M

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
Assets
Cash And Equivalents	39.37M	28.86M	22.22M	25.8M	25.44M
Short Term Investments	55.62M	99.98M	66.59M	77.69M	404K
Total Cash And Short Term Investments	94.99M	129M	88.82M	103M	25.84M
Accounts Receivable, Total	-	-	2.58M	1.75M	1.68M
Total Receivables	-	-	2.58M	1.75M	1.68M
Inventory	-	-	2.61M	2.85M	1.56M
Prepaid Expenses	5.39M	7.75M	7.58M	7.7M	7.47M
Other Current Assets, Total	-	1.22M	1.78M	1.74M	1.29M
Total Current Assets	100M	138M	103M	118M	37.84M
Gross Property Plant And Equipment	2.88M	2.23M	1.87M	2.15M	1.8M
Accumulated Depreciation	-632K	-342K	-603K	-895K	-1.17M
Net Property Plant And Equipment	2.24M	1.88M	1.27M	1.26M	627K
Long-term Investments	-	-	17.26M	-	-
Other Long-Term Assets, Total	2.51M	3.9M	4.51M	1.35M	360K
Total Assets	105M	144M	126M	120M	38.83M
Liabilities
Accounts Payable, Total	6.41M	4.64M	7.76M	8.98M	2.12M
Accrued Expenses, Total	10M	11.4M	11.85M	14.28M	7.69M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	7.81M	-	41.12M
Current Portion of Leases	534K	582K	628K	491K	84K
Unearned Revenue Current, Total	-	-	1.85M	1.37M	2.28M
Total Current Liabilities	16.95M	16.63M	29.9M	25.12M	53.28M
Long-Term Debt	30.39M	31.19M	23.99M	39.62M	-
Long-Term Leases	1.32M	738K	116K	83K	-
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	48.66M	48.56M	54M	64.83M	53.28M
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	24K	34K	35K	44K	1K
Additional Paid In Capital	298M	402M	413M	493M	498M
Retained Earnings	-241M	-306M	-340M	-437M	-512M
Comprehensive Income and Other	42K	-8K	-149K	-300K	-169K
Total Common Equity	56.48M	95.04M	72.4M	55.31M	-14.46M
Total Equity	56.48M	95.04M	72.4M	55.31M	-14.46M
Total Liabilities And Equity	105M	144M	126M	120M	38.83M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	819K	1.13M	1.15M	1.47M	1.48M
ECS Total Common Shares Outstanding	817K	1.13M	1.15M	1.47M	1.48M
Book Value / Share	69.09	84.16	62.83	37.65	-9.77
Tangible Book Value	56.48M	95.04M	72.4M	55.31M	-14.46M
Tangible Book Value Per Share	69.09	84.16	62.83	37.65	-9.77
Total Debt	32.24M	32.51M	32.54M	40.2M	41.2M
Net Debt	-62.75M	-96.33M	-56.28M	-63.29M	15.36M
Debt Equivalent Oper. Leases	5.6M	5.6M	5.6M	5.6M	-
Account Code - Inventory Valuation	3	3	3	5	5
Inventories - Raw Materials, Total	-	-	1.06M	1.7M	531K
Inventories - Work In Process, Total	-	-	1.47M	884K	940K
Inventories - Finished Goods, Total	-	-	88K	266K	85K
Machinery, Total	307K	902K	1.06M	1.12M	1.39M
Full Time Employees	24	28	43	56	25

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
Net Income	-70.25M	-65.05M	-33.92M	-96.78M	-74.96M
Depreciation & Amortization - CF	486K	645K	799K	842K	750K
Depreciation & Amortization, Total	486K	645K	799K	842K	750K
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-467K	124K	996K	682K	-1.11M
Stock-Based Compensation (CF)	5.68M	5.97M	7.9M	8.32M	5.01M
Other Operating Activities, Total	949K	1.02M	-45.78M	3.44M	1.5M
Change In Accounts Receivable	-	-	-2.58M	828K	84K
Change In Inventories	-	-	-2.42M	-1.37M	1.63M
Change In Accounts Payable	584K	-1.9M	3.23M	1.15M	-6.84M
Change in Other Net Operating Assets	-593K	-4M	425K	-132K	-608K
Cash from Operations	-63.61M	-63.18M	-71.34M	-83.01M	-74.55M
Capital Expenditure	-475K	-258K	-225K	-340K	-234K
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	281K	-	-
Investment in Marketable and Equity Securities, Total	-16M	-44.53M	14.98M	9.97M	74.46M
Other Investing Activities, Total	-	-	46.49M	-	-
Cash from Investing	-16.47M	-44.79M	61.53M	9.63M	74.23M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	6.63M	-	-	39.84M	-
Total Debt Issued	6.63M	-	-	39.84M	-
Long-Term Debt Repaid, Total	-1.67M	-	-	-33.28M	-
Total Debt Repaid	-1.67M	-	-	-33.28M	-
Issuance of Common Stock	54.17M	97.48M	3.66M	71.79M	56K
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-932K	-22K	-491K	-1.4M	-15K
Cash from Financing	58.2M	97.46M	3.17M	76.96M	41K
Foreign Exchange Rate Adjustments	-	-	-	-	-79K
Net Change in Cash	-21.89M	-10.51M	-6.64M	3.58M	-358K
Supplemental Items
Cash Interest Paid	2.64M	2.79M	2.78M	2.88M	3.97M
Cash Income Tax Paid (Refund)	-	-	-	64K	269K
Levered Free Cash Flow	-36.78M	-38.46M	-41.5M	-48.09M	-53.26M
Unlevered Free Cash Flow	-34.66M	-36.21M	-39.28M	-45.51M	-49.84M
Change In Net Working Capital	-2.49M	3.95M	164K	-3.62M	10.5M
Net Debt Issued / Repaid	4.96M	-	-	6.56M	-

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
Profitability
Return on Assets	-41.49	-31.23	-35.62	-47.02	-56.45
Return on Total Capital	-47.6	-35.92	-41.37	-57.83	-73.4
Return On Equity %	-114.16	-85.87	-40.51	-151.56	-367
Return on Common Equity	-114.16	-85.87	-40.51	-151.56	-367
Margin Analysis
Gross Profit Margin %	-	-	93.86	86.38	99.85
SG&A Margin	-	-	196.84	215.85	159.79
EBITDA Margin %	-	-	-631.39	-685.61	-453.38
EBITA Margin %	-	-	-633.66	-687.78	-455.12
EBIT Margin %	-	-	-633.66	-687.78	-455.12
Income From Continuing Operations Margin %	-	-	-279.34	-717.71	-475.26
Net Income Margin %	-	-	-279.34	-717.71	-475.26
Net Avail. For Common Margin %	-	-	-279.34	-717.71	-475.26
Normalized Net Income Margin	-	-	-174.26	-443.36	-297.01
Levered Free Cash Flow Margin	-	-	-341.8	-356.65	-337.65
Unlevered Free Cash Flow Margin	-	-	-323.48	-337.5	-315.99
Asset Turnover
Asset Turnover	-	-	0.09	0.11	0.2
Fixed Assets Turnover	-	-	7.71	10.69	23.84
Receivables Turnover (Average Receivables)	-	-	-	5.89	9.05
Inventory Turnover (Average Inventory)	-	-	0.55	0.67	0.01
Short Term Liquidity
Current Ratio	5.92	8.29	3.46	4.68	0.71
Quick Ratio	5.6	7.75	3.06	4.19	0.52
Operating Cash Flow to Current Liabilities	-3.75	-3.8	-2.39	-3.3	-1.4
Days Sales Outstanding (Average Receivables)	-	-	-	61.98	40.34
Days Outstanding Inventory (Average Inventory)	-	-	662.63	542.93	33.53K
Average Days Payable Outstanding	-	-	693.6	1.47K	-1.59K
Cash Conversion Cycle (Average Days)	-	-	-	-865.27	35.16K
Long Term Solvency
Total Debt/Equity	57.09	34.21	44.94	72.68	-284.98
Total Debt / Total Capital	36.34	25.49	31.01	42.09	154.06
LT Debt/Equity	56.14	33.6	33.29	71.79	-
Long-Term Debt / Total Capital	35.74	25.04	22.97	41.58	-
Total Liabilities / Total Assets	46.28	33.82	42.72	53.96	137.24
EBIT / Interest Expense	-20.23	-17.29	-21.62	-22.44	-13.13
EBITDA / Interest Expense	-20	-17.05	-21.34	-22.2	-12.96
(EBITDA - Capex) / Interest Expense	-20.14	-17.12	-21.41	-22.29	-13
Total Debt / EBITDA	-0.47	-0.53	-0.43	-0.44	-0.58
Net Debt / EBITDA	0.92	1.57	0.74	0.69	-0.22
Total Debt / (EBITDA - Capex)	-0.47	-0.53	-0.43	-0.44	-0.58
Net Debt / (EBITDA - Capex)	0.91	1.57	0.74	0.69	-0.22
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	11.05	16.98
Gross Profit, 1 Yr. Growth %	-	-	-	2.19	35.22
EBITDA, 1 Yr. Growth %	34.99	-9.96	23.69	20.59	-22.65
EBITA, 1 Yr. Growth %	34.98	-9.8	23.8	20.54	-22.59
EBIT, 1 Yr. Growth %	34.98	-9.8	23.8	20.54	-22.59
Earnings From Cont. Operations, 1 Yr. Growth %	34.09	-7.4	-47.86	185.33	-22.54
Net Income, 1 Yr. Growth %	34.09	-7.4	-47.86	185.33	-22.54
Normalized Net Income, 1 Yr. Growth %	34.09	-7.4	-47.96	182.55	-21.64
Diluted EPS Before Extra, 1 Yr. Growth %	-19.76	-25.03	-56.77	132.66	-27.19
Accounts Receivable, 1 Yr. Growth %	-	-	-	-32.1	-3.83
Inventory, 1 Yr. Growth %	-	-	2.71K	9.23	-45.46
Net Property, Plant and Equip., 1 Yr. Growth %	1.24K	-16	-32.84	-0.71	-9.91
Total Assets, 1 Yr. Growth %	2.63	36.58	-11.97	-4.95	-67.68
Tangible Book Value, 1 Yr. Growth %	-15.19	68.26	-23.82	-23.6	-126.14
Common Equity, 1 Yr. Growth %	-15.19	68.26	-23.82	-23.6	-126.14
Cash From Operations, 1 Yr. Growth %	49.08	-0.67	12.91	16.36	-10.19
Capital Expenditures, 1 Yr. Growth %	234.51	-45.68	-12.79	51.11	-31.18
Levered Free Cash Flow, 1 Yr. Growth %	53.04	4.55	7.91	16.03	10.74
Unlevered Free Cash Flow, 1 Yr. Growth %	53.48	4.49	8.46	16.03	9.52
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	-	13.98
Gross Profit, 2 Yr. CAGR %	-	-	-	-	17.55
EBITDA, 2 Yr. CAGR %	28.82	10.25	5.53	22.13	-3.42
EBITA, 2 Yr. CAGR %	28.82	10.34	5.67	22.16	-3.41
EBIT, 2 Yr. CAGR %	28.82	10.34	5.67	22.16	-3.41
Earnings From Cont. Operations, 2 Yr. CAGR %	28.65	11.43	-30.52	21.97	48.67
Net Income, 2 Yr. CAGR %	28.65	11.43	-30.52	21.97	48.67
Normalized Net Income, 2 Yr. CAGR %	28.35	11.43	-30.58	21.26	48.8
Diluted EPS Before Extra, 2 Yr. CAGR %	-20.38	-22.44	-43.07	0.29	30.15
Accounts Receivable, 2 Yr. CAGR %	-	-	-	-	-19.19
Inventory, 2 Yr. CAGR %	-	-	-	453.87	-22.82
Net Property, Plant and Equip., 2 Yr. CAGR %	432.96	235.97	-24.89	-18.34	-29.63
Total Assets, 2 Yr. CAGR %	56.58	18.39	9.65	-8.53	-44.58
Tangible Book Value, 2 Yr. CAGR %	58.36	19.46	13.22	-23.71	-55.31
Common Equity, 2 Yr. CAGR %	58.36	19.46	13.22	-23.71	-55.31
Cash From Operations, 2 Yr. CAGR %	28.76	21.69	5.9	14.62	2.22
Capital Expenditures, 2 Yr. CAGR %	228.56	34.79	-31.18	14.8	1.98
Levered Free Cash Flow, 2 Yr. CAGR %	27.54	26.49	6.22	11.82	13.36
Unlevered Free Cash Flow, 2 Yr. CAGR %	26.49	26.64	6.46	12.1	12.73
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	14.3	14.33	14.56	10.33	4.88
EBITA, 3 Yr. CAGR %	14.32	14.39	14.65	10.41	4.92
EBIT, 3 Yr. CAGR %	14.32	14.39	14.65	10.41	4.92
Earnings From Cont. Operations, 3 Yr. CAGR %	14.27	15.29	-13.49	11.27	4.84
Net Income, 3 Yr. CAGR %	14.27	15.29	-13.49	11.27	4.84
Normalized Net Income, 3 Yr. CAGR %	14.27	15.11	-13.55	10.84	4.84
Diluted EPS Before Extra, 3 Yr. CAGR %	-26.73	-21.96	-36.17	-8.98	-9.86
Inventory, 3 Yr. CAGR %	-	-	-	-	155.77
Net Property, Plant and Equip., 3 Yr. CAGR %	209.08	187.89	96.44	-17.57	-30.71
Total Assets, 3 Yr. CAGR %	20.07	49.61	7.25	4.55	-35.34
Tangible Book Value, 3 Yr. CAGR %	11.52	61.59	2.83	-0.7	-46.62
Common Equity, 3 Yr. CAGR %	11.52	61.59	2.83	-0.7	-46.62
Cash From Operations, 3 Yr. CAGR %	18.77	18.09	18.69	9.28	5.67
Capital Expenditures, 3 Yr. CAGR %	101.57	80.32	16.58	-10.55	-3.2
Levered Free Cash Flow, 3 Yr. CAGR %	15.91	19.36	19.97	9.34	11.46
Unlevered Free Cash Flow, 3 Yr. CAGR %	14.33	18.68	20.26	9.51	11.24
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	114.73	36.75	10.71	17.39	7
EBITA, 5 Yr. CAGR %	114.54	36.8	10.78	17.44	7.06
EBIT, 5 Yr. CAGR %	114.54	36.8	10.78	17.44	7.06
Earnings From Cont. Operations, 5 Yr. CAGR %	115.37	37.32	-6.35	17.92	7.43
Net Income, 5 Yr. CAGR %	115.37	37.32	-6.35	17.92	7.43
Normalized Net Income, 5 Yr. CAGR %	115.37	37.32	-6.39	17.53	7.43
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-33.77	-13.72	-15.12
Net Property, Plant and Equip., 5 Yr. CAGR %	211.28	115.03	75.52	73.92	30.29
Total Assets, 5 Yr. CAGR %	164.22	91.46	15.79	22.88	-17.64
Tangible Book Value, 5 Yr. CAGR %	30.65	27.94	12.2	19.68	-26.32
Common Equity, 5 Yr. CAGR %	30.65	27.94	12.2	19.68	-26.32
Cash From Operations, 5 Yr. CAGR %	118.41	47.23	13.44	16.69	11.8
Capital Expenditures, 5 Yr. CAGR %	175.37	41.8	31.14	50.52	10.51
Levered Free Cash Flow, 5 Yr. CAGR %	119.96	44.25	11.93	16.29	17.25
Unlevered Free Cash Flow, 5 Yr. CAGR %	117.36	43.56	11.11	16.01	17.16